期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

病毒耐药的现状及临床治疗策略

Situation and Clinical Treatment on the Aspect of Virus Drug-Tolerance
下载PDF
导出
摘要 随着抗病毒药物的广泛应用 ,病毒耐药情况也变得越来越严重。正确选择抗病毒药物治疗的适应证 。 As the antiviriotics are used widely in clinical practice,the situation of virus drug tolerance become much worse today.Selecting the antivirotics correctly according to the indications and monitoring the situation of virus drug tolerance may contribute greatly to reduce the development of virus drug tolerance.
作者 李江 李春凤 黄仁彬
机构地区 桂林医学院附属医院药剂科 广西医科大学药理教研室
出处 《华夏医学》 2004年第1期118-121,共4页 Acta Medicinae Sinica
关键词 病毒 耐药性 适应证 virus drug tolerance indication
分类号 R978.7 [医药卫生—药品]
  • 相关文献

参考文献6

二级参考文献46

  • 1[1]Yuen MF,Hui CK,Cheng CC,et al.Long-term follow-up of interferon-alfa treatment in Chinese patients with chronic hepatitis B infection:the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complication.Hepatology,2001,34:139-145.
  • 2[2]Honkop P,de Man RA,Niesters HGM,et al.Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.Hepatology,2000,32:635-640.
  • 3[3]Schlm SW,Heathcote J,Cianciara J,et al.Lamivudine and a-interferon combination treatment of patients with chronic hepatits B infection:a randomized trial.Gut,2000,46:562-568.
  • 4[4]Serfaty LWR,Thabut D,Zoulim F,et al.Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone:results of a pilot study.Hepatology,2001,34:573-577.
  • 5[5]Lau GKK,Tsiang M,Hou J,et al.Combination therapy with lamivudine and famciclovir for chronic hepatitis Binfected Chinese patients:a viral dynamics study.Hepatology,2000,32:394-399.
  • 6[6]Liaw YF,Tsai SL,Chien RN,et al.Prednisolone proming enhances Th 1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.Hepatology,2000,32:604-609.
  • 7[7]Blackberg J,Kidd-Ljunggren K.Occult hepatitis B Virus after acute self-limited infection persisting for 30 years without sequence variation.J Hepatology,2000,33:992-997.
  • 8[8]Brechot C,Thiers V,Kremsdorf,et al.Persistent hepatitis B Virus infection in subjects without hepatitis B surface antigen:clincally significant or purely"occult"?Hepatology,2001,34:194-203.
  • 9[9]Prange R,Werr M.DNA-mediated immunization to hepatitis B virus envelop proteins:Pre S antigen secretion enhance the hemoral response.Vaccine,1999,17:617-623.
  • 10[10]Beterams G,Nassal M.Significant interference with hepatitis B Virus replication by a core-nuclease fusion protein.J Biol Chem,2001,276:8875-8883.

共引文献81

华夏医学
2004年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部